Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

5articles mentioning drugs

8drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: β-blocker ×

β-blocker

This drug is selected. Its supporting articles are shown below.

β-Blocker5

Articles mentioning β-blocker

5 articles · page 1 of 1

Assessment of β-blocker use and all-cause mortality in patients with myocardial infarction: a real-world analysis of the NHANES 1999–2018 database

openhrt · abstract · 2025-11-13 · 3 matching annotations

93.0%

β-blocker myocardial infarction NHANES MI

…up of 84.6 months, this study evaluated the association between β-blocker use and all-cause mortality. The unadjusted analysis showed a s…

Use of beta-blockers and in-hospital mortality in patients with Takotsubo cardiomyopathy: systematic review and meta-analysis

openhrt · abstract · 2025-10-31 · 2 matching annotations

90.1%

β-Blockers β-Blocker beta-blockers BBs Takotsubo cardiomyopathy PubMed Cochrane Embase coronary disease

… of TC remains poorly understood, and the use of beta-blockers (β-Blockers) appears promising. However, the impact of β-blockers in acute-…

Treatment gaps in guideline-directed medical therapy for HFrEF in Singapore: findings from a multicentre retrospective cohort study

bmjopen · abstract · 2026-03-12 · 1 matching annotations

80.6%

ARNI β-blocker ARB ACEi heart failure-related quadruple therapy heart failure with reduced ejection fraction

…e therapy at discharge in 2022. Prescription rates for ACEi/ARB/ARNI (67%), beta-blockers (89%), MRAs (40%), and SGLT2 inhibitors (4…

Non-adherence to medications prescribed to patients with heart failure in general practice: prevalence, risk factors and association with mortality and hospitalisation

openhrt · abstract · 2025-09-23 · 1 matching annotations

89.8%

ACE inhibitor angiotensin receptor blocker β-blocker mineralocorticoid receptor antagonist heart failure Clinical Practice Research Datalink HF CVD

…ary 2009 to 31 December 2018. We evaluated non-adherence to any ACE inhibitor, angiotensin receptor blocker, β-blocker or mineralocorticoid r…

Guideline-directed medical therapy and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: analysis of two nationwide retrospective cohort studies

bmjopen · abstract · 2025-08-26 · 1 matching annotations

94.3%

statin β-blocker GDMT dual antiplatelet drugs ACE inhibitor/angiotensin receptor blocker advanced renal dysfunction acute coronary syndrome GDMT Chinese National Electronic Disease Surveillance System Platform CNEDSSP+1 more

…bitor/angiotensin receptor blocker, dual antiplatelet drugs and statin) could improve in-hospital mortality in acute coronary syndrome…